Ferrando Arny A, Sheffield-Moore Melinda, Yeckel Catherine W, Gilkison Charles, Jiang Jie, Achacosa Alison, Lieberman Steven A, Tipton Kevin, Wolfe Robert R, Urban Randall J
Department of Surgery, The University of Texas Medical Branch, Galveston, Texas 77550, USA.
Am J Physiol Endocrinol Metab. 2002 Mar;282(3):E601-7. doi: 10.1152/ajpendo.00362.2001.
We investigated the effects of 6 mo of near-physiological testosterone administration to older men on skeletal muscle function and muscle protein metabolism. Twelve older men (> or =60 yr) with serum total testosterone concentrations <17 nmol/l (480 ng/dl) were randomly assigned in double-blind manner to receive either placebo (n = 5) or testosterone enanthate (TE; n = 7) injections. Weekly intramuscular injections were given for the 1st mo to establish increased blood testosterone concentrations at 1 mo and then changed to biweekly injections until the 6-mo time point. TE doses were adjusted to maintain nadir serum testosterone concentrations between 17 and 28 nmol/l. Lean body mass (LBM), muscle volume, prostate size, and urinary flow were measured at baseline and at 6 mo. Protein expression of androgen receptor (AR) and insulin-like growth factor I, along with muscle strength and muscle protein metabolism, were measured at baseline and at 1 and 6 mo of treatment. Hematological parameters were followed monthly throughout the study. Older men receiving testosterone increased total and leg LBM, muscle volume, and leg and arm muscle strength after 6 mo. LBM accretion resulted from an increase in muscle protein net balance, due to a decrease in muscle protein breakdown. TE treatment increased expression of AR protein at 1 mo, but expression returned to pre-TE treatment levels by 6 mo. IGF-I protein expression increased at 1 mo and remained increased throughout TE administration. We conclude that physiological and near-physiological increases of testosterone in older men will increase muscle protein anabolism and muscle strength.
我们研究了对老年男性进行6个月接近生理水平的睾酮给药对骨骼肌功能和肌肉蛋白质代谢的影响。12名血清总睾酮浓度<17 nmol/l(480 ng/dl)的老年男性(≥60岁)以双盲方式随机分配,分别接受安慰剂(n = 5)或庚酸睾酮(TE;n = 7)注射。在第1个月每周进行肌肉注射,以使1个月时血睾酮浓度升高,然后改为每两周注射一次,直至6个月时间点。调整TE剂量以维持最低血清睾酮浓度在17至28 nmol/l之间。在基线和6个月时测量去脂体重(LBM)、肌肉体积、前列腺大小和尿流率。在基线以及治疗1个月和6个月时测量雄激素受体(AR)和胰岛素样生长因子I的蛋白质表达,以及肌肉力量和肌肉蛋白质代谢。在整个研究过程中每月跟踪血液学参数。接受睾酮治疗的老年男性在6个月后总LBM和腿部LBM、肌肉体积以及腿部和手臂肌肉力量均增加。LBM增加是由于肌肉蛋白质净平衡增加,这是由于肌肉蛋白质分解减少所致。TE治疗在1个月时增加了AR蛋白的表达,但到6个月时表达恢复到TE治疗前的水平。IGF-I蛋白表达在1个月时增加,并在整个TE给药期间持续增加。我们得出结论,老年男性睾酮的生理和接近生理水平的升高将增加肌肉蛋白质合成代谢和肌肉力量。